Aharon Schwartz is a director of Protalix BioTherapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Protalix BioTherapeutics, Inc.
3 Oct 23
4
Protalix BioTherapeutics, Inc.
5 Jan 23
4
Protalix BioTherapeutics, Inc.
9 Sep 22
4
Protalix BioTherapeutics, Inc.
13 Apr 20
4
Foamix Pharmaceuticals Ltd.
11 Mar 20
4
Foamix Pharmaceuticals Ltd.
3 Mar 20
4
Protalix BioTherapeutics, Inc.
22 Jan 20
4
Foamix Pharmaceuticals Ltd.
20 May 19
4
Foamix Pharmaceuticals Ltd.
6 Dec 18
4
Foamix Pharmaceuticals Ltd.
10 May 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Sep 23 | PLX Protalix BioTherapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.66 | 61,676 | 102.38 k | 61,676 |
3 Jan 23 | PLX Protalix BioTherapeutics | Common Stock | Buy | Acquire P | No | No | 1.4165 | 110,000 | 155.82 k | 174,000 |